Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNRHR known ✓ | P30968 | 12/20 | 0.88 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.75 |
| ▸ | DRD1 | P21728 | 1/20 | 0.73 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.73 |
| ▸ | MRGPRX2 | Q96LB1 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL61985 | 0.99 | GNRHR (0.86) | GNRHRABCB11DRD1OPRM1MRGPRX2 | |
| SCHEMBL6053414 | 0.99 | GNRHR (0.86) | GNRHRABCB11DRD1OPRM1MRGPRX2 | |
| Glycine SCHEMBL9408385 | 0.98 | GNRHR (0.84) | GNRHRABCB11DRD1OPRM1MRGPRX2 | |
| Dopamine SCHEMBL7286916 | 0.94 | GNRHR (0.80) | GNRHRABCB11DRD1OPRM1MRGPRX2 | |
| SCHEMBL28837464 | 0.94 | GNRHR (0.78) | GNRHRABCB11DRD1OPRM1MRGPRX2 | |
| Ganirelix SCHEMBL20521061 | 0.94 | GNRHR (1.00) | GNRHRABCB11DRD1OPRM1MRGPRX2 | |
| Ganirelix SCHEMBL29402980 | 0.94 | GNRHR (1.00) | GNRHRABCB11DRD1OPRM1MRGPRX2 | |
| Ganirelix SCHEMBL4405429 | 0.93 | GNRHR (0.98) | GNRHRABCB11DRD1OPRM1MRGPRX2 | |
| Ganirelix SCHEMBL19712192 | 0.93 | GNRHR (0.98) | GNRHRABCB11DRD1OPRM1MRGPRX2 | |
| Ganirelix SCHEMBL719978 | 0.93 | GNRHR (0.98) | GNRHRABCB11DRD1OPRM1MRGPRX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1515 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746850-A1 | EXTENDED RELEASE DRUG-LOADED MICROPARTICLES | Ferring BV (NL) | 2026-05-27 | — | — | EP | claimed |
| US-20260076872-A1 | POLYMER VIALS WITH SUBSTANTIALLY FLAT BOTTOMS AND INJECTION STRETCH BLOW MOLDING METHODS FOR MAKING THE SAME | SIO2 MEDICAL PRODUCTS LLC (US) | 2026-03-19 | — | — | US | claimed |
| US-20250242092-A1 | SiOx BARRIER FOR PHARMACEUTICAL PACKAGE AND COATING PROCESS | SIO2 MEDICAL PRODUCTS INC (US) | 2025-07-31 | — | — | US | claimed |
| US-20250109170-A1 | METHOD FOR MANUFACTURING GANIRELIX | ANYGEN CO., LTD. (KR) | 2025-04-03 | — | — | US | claimed |
| US-12257371-B2 | SiOx barrier for pharmaceutical package and coating process | SIO2 MEDICAL PRODUCTS, LLC (US) | 2025-03-25 | — | — | US | claimed |
| CN-113929751-B | Preparation method of ganirelix acetate | 深圳翰宇药业股份有限公司 | 2025-01-24 | — | — | CN | claimed |
| WO-2025017533-A1 | EXTENDED RELEASE DRUG-LOADED MICROPARTICLES | FERRING B.V. (NL) | 2025-01-23 | — | — | WO | claimed |
| CN-118812662-A | Method for preparing ganirelix acetate | 杭州昊肽生物科技有限公司 | 2024-10-22 | — | — | CN | claimed |
| US-20240282425-A1 | AUTHENTICATION METHODS AND SYSTEMS FOR DISPENSED PRESCRIPTIONS | LOW GORDON KEITH (US) | 2024-08-22 | — | — | US | claimed |
| CN-118348146-A | HPLC detection method for migration amount of simethicone in medicine | 南京臣功制药股份有限公司 | 2024-07-16 | — | — | CN | claimed |
| US-20130041241-A1 | PECVD COATING METHODS FOR CAPPED SYRINGES, CARTRIDGES AND OTHER ARTICLES | OAKTREE FUND ADMINISTRATION, LLC | 2013-02-14 | — | — | US | claimed |
| US-20130004577-A1 | COATED TABLET | NIPPON SHINYAKU (JP) | 2013-01-03 | — | — | US | claimed |
| CN-102584945-A | Preparation method for ganirelix acetate | SHENZHEN HYBIO PHARMACEUTICAL | 2012-07-18 | — | — | CN | claimed |
| US-20100233262-A1 | COATED TABLET | NIPPON SHINYAKU CO., LTD. (JP) | 2010-09-16 | — | — | US | claimed |
| WO-2008116165-A9 | METHODS AND SYSTEMS OF DELIVERING MEDICATION VIA INHALATION | NEXT SAFETY INC (US) | 2009-06-11 | — | — | WO | claimed |
| EP-2057985-A1 | COATED TABLET | Nippon Shinyaku Co., Ltd. (JP) | 2009-05-13 | — | — | EP | claimed |
| WO-2008116165-A2 | METHODS AND SYSTEMS OF DELIVERING MEDICATION VIA INHALATION | NEXT SAFETY, INC. (US) | 2008-09-25 | — | — | WO | claimed |
| US-20080066741-A1 | METHODS AND SYSTEMS OF DELIVERING MEDICATION VIA INHALATION | HUNTER, CHARLES ERIC | 2008-03-20 | — | — | US | claimed |
| WO-2005048979-A2 | PHARMACEUTICAL COMPOSITION HAVING CASING WITH MULTIPLE MICRO TABLETS | TORRENT PHARMACEUTICALS LIMITED (IN) | 2005-06-02 | — | — | WO | claimed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250109170-A1 | METHOD FOR MANUFACTURING GANIRELIX | VIP, GLP1R, CCKBR | GNRHR 43/4885ABCB11 2702/4885DRD1 3889/4885 |
| US-20260076872-A1 | POLYMER VIALS WITH SUBSTANTIALLY FLAT BOTTOMS AND INJECTION STRETCH BLOW MOLDING METHODS FOR MAKING THE SAME | MEN1, MYO1G, IL2 | GNRHR 871/4885ABCB11 3369/4885DRD1 4117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.